Literature DB >> 19395465

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

Satoru Iwasa1, Masashi Ando, Makiko Ono, Taizo Hirata, Mayu Yunokawa, Eriko Nakano, Kan Yonemori, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Noriyuki Katsumata, Yasuhiro Fujiwara.   

Abstract

This case report details a relapse with malignant transformation after the completion of bleomycin, etoposide and cisplatin chemotherapy for primary mediastinal seminoma, although the residual mass after chemotherapy was <3 cm in size and did not display an increased uptake of fluorodeoxyglucose when examined using positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395465     DOI: 10.1093/jjco/hyp034

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Intensity modulated radiation therapy to treat primary female mediastinal seminoma and massive pericardial effusion: A case report.

Authors:  Jun Cao; Yan Zhou; Fangwen Zou; Jin-An Ma; Chunhong Hu
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

2.  Primary mediastinal seminoma; resistance and relapse: An aggressive entity.

Authors:  Ankita Nachankar; Rahul Krishnatry; Amit Joshi; Vanita Noronha; Jai Prakash Agarwal
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

3.  Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma.

Authors:  Yirui Zhai; Bo Chen; Xiaoli Feng; Kan Liu; Shulian Wang; Zhouguang Hui; Qinfu Feng; Junling Li; Zefen Xiao; Jima Lv; Yushun Gao; Yueping Liu; Hui Fang; Jianyang Wang; Lei Deng; Wenyang Liu; Wenqing Wang; Zongmei Zhou; Ye-Xiong Li
Journal:  Radiat Oncol       Date:  2022-03-26       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.